Pettinga Financial Advisors, LLC Bristol Myers Squibb CO Transaction History

Pettinga Financial Advisors, LLC

$478 Million
Q3 2025

A detailed history of Pettinga Financial Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Pettinga Financial Advisors, LLC holds 10,881 shares of BMY stock, worth $509,339. This represents 0.1% of its overall portfolio holdings.

Number of Shares

10,881

Previous 11,058 1.6%

Holding current value

$509,339

Previous $511,000 4.11%

% of portfolio

0.1%

Previous 0.12%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 21, 2025	SELL	$43.31 - $48.98 $7,665 - $8,669	-177 Reduced 1.6%	10,881 $490,000
Q1 2025 May 02, 2025	SELL	$53.9 - $63.11 $2,695 - $3,155	-50 Reduced 0.45%	11,058 $674,000
Q3 2024 Oct 23, 2024	BUY	$39.66 - $51.75 $35,138 - $45,850	886 Added 8.67%	11,108 $574,000
Q2 2024 Jul 25, 2024	SELL	$40.25 - $52.99 $11,712 - $15,420	-291 Reduced 2.77%	10,222 $424,000
Q1 2024 Apr 17, 2024	BUY	$47.98 - $54.4 $9,596 - $10,880	200 Added 1.94%	10,513 $570,000

Q4 2023 Jan 18, 2024	BUY	$48.48 - $57.85 $969 - $1,157	20 Added 0.19%	10,313 $529,000
Q2 2023 Jul 17, 2023	SELL	$63.71 - $70.74 $6,371 - $7,073	-100 Reduced 0.96%	10,293 $658,000
Q1 2023 Apr 20, 2023	BUY	$65.71 - $74.53 $1,971 - $2,235	30 Added 0.29%	10,393 $720,000
Q4 2022 Jan 12, 2023	SELL	$68.48 - $81.09 $8,628 - $10,217	-126 Reduced 1.2%	10,363 $0
Q2 2022 Jul 19, 2022	SELL	$72.62 - $79.98 $10,893 - $11,997	-150 Reduced 1.41%	10,489 $808,000
Q1 2022 Apr 27, 2022	SELL	$61.48 - $73.72 $81,461 - $97,679	-1,325 Reduced 11.07%	10,639 $777,000
Q4 2021 Feb 09, 2022	BUY	$53.63 - $62.52 $27,887 - $32,510	520 Added 4.54%	11,964 $746,000
Q3 2021 Oct 29, 2021	BUY	$59.17 - $69.31 $11,123 - $13,030	188 Added 1.67%	11,444 $677,000
Q2 2021 Aug 12, 2021	SELL	$61.91 - $67.42 $6,376 - $6,944	-103 Reduced 0.91%	11,256 $752,000
Q1 2021 Apr 29, 2021	SELL	$59.34 - $66.74 $7,239 - $8,142	-122 Reduced 1.06%	11,359 $717,000
Q4 2020 Jan 29, 2021	SELL	$57.74 - $65.43 $6,755 - $7,655	-117 Reduced 1.01%	11,481 $712,000
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $28,715 - $31,820	-500 Reduced 4.13%	11,598 $699,000
Q2 2020 Jul 22, 2020	SELL	$54.82 - $64.09 $3,672 - $4,294	-67 Reduced 0.55%	12,098 $711,000
Q1 2020 May 11, 2020	SELL	$46.4 - $67.43 $17,353 - $25,218	-374 Reduced 2.98%	12,165 $678,000
Q4 2019 Feb 07, 2020	SELL	$49.21 - $64.19 $11,170 - $14,571	-227 Reduced 1.78%	12,539 $805,000
Q3 2019 Oct 17, 2019	SELL	$42.77 - $50.71 $2,138 - $2,535	-50 Reduced 0.39%	12,766 $647,000
Q2 2019 Jul 31, 2019	BUY	$44.62 - $49.34 $142,070 - $157,098	3,184 Added 33.06%	12,816 $581,000
Q4 2018 Feb 01, 2019	BUY	$48.76 - $63.23 $469,656 - $609,031	9,632 New	9,632 $501,000

Others Institutions Holding BMY

# of Institutions

2,717

Shares Held

1.58B

Call Options Held

28M

Put Options Held

28.4M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.5B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pettinga Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pettinga Financial Advisors, LLC with notifications on news.

Account

Pettinga Financial Advisors, LLC Bristol Myers Squibb CO Transaction History